Found 5 matching trials
Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age PHASE3 Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...
Show More Location
320, Novartis Investigational Site
Learn More & Join Trial
Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup PHASE3 The study primarily aims to evaluate immunogenicity and safety of influenza...
Show More Learn More & Join Trial
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above PHASE3 The present study is designed to confirm the safety and immunogenicity of c...
Show More Location
Rostock University, Department of Tropical Medicine and Infectious Diseases
Learn More & Join Trial
Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents PHASE2 The present study is the first study designed to evaluate safety, tolerabil...
Show More Learn More & Join Trial
Randomized Influenza Vaccine Evaluation of Immune Response PHASE4 Licensed influenza vaccines are manufactured with a variety of technologies...
Show More Location
Marshfield Clinic - Marshfield Center
Learn More & Join Trial